Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q3 2022 · 10-Q
Revenue$33.91M$33.91M+2.1% vs Q3 2021 Net Income$2.71M$2.71M+34.0% vs Q3 2021 EPS Diluted$0.01$0.01±0.0% vs Q3 2021 Gross Profit$16,164,000−11.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived$3,345,000−68.6% Free Cash Flowderived$1,214,000−69.5% Margins · derivedGross margin47.7%−7.1 pt vs Q3 2021
Operating margin16.9%−3.0 pt vs Q3 2021
Net margin8.0%+1.9 pt vs Q3 2021
ended Sep 30, 2022 · filed Nov 8, 2022 · 39 d after period end